Progyny (NASDAQ: PGNY ), a company specializing in fertility benefits management, reported a 5.8% increase in its premarket value after indicating that its fourth-quarter results will marginally surpass the forecast previously provided.

Progyny's CEO, Pete Anevski, expressed satisfaction with the company's performance in the fourth quarter. He stated that member activity had maintained a positive trend in comparison to their earlier projections.

In the company's official statement, Anevski further revealed that they now anticipate the fourth-quarter results for revenue, net income, and adjusted Ebitda to exceed the ranges they had initially provided in November.